Assessing the therapeutic role of trehalose and hyaluronic acid: implications for patient care.

IF 1.4 4区 医学 Q3 OPHTHALMOLOGY
Ahmed Gawash, Alexa Simonetti, David F Lo, Don D Shamilov, Aman Kumar, Jae-Chiang Wong
{"title":"Assessing the therapeutic role of trehalose and hyaluronic acid: implications for patient care.","authors":"Ahmed Gawash, Alexa Simonetti, David F Lo, Don D Shamilov, Aman Kumar, Jae-Chiang Wong","doi":"10.1007/s10792-024-03308-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This Systematic review aims to assess the efficacy of trehalose and hyaluronic acid in enhancing ocular recovery post-cataract surgery, focusing on their impact on tear film stability, ocular surface integrity, and patient-reported outcomes.</p><p><strong>Methods: </strong>A comprehensive search was conducted across MEDLINE, PubMed, and Cochrane Library databases to identify randomized controlled trials investigating the efficacy of trehalose, hyaluronic acid, or their combination in post-cataract surgery care. The inclusion criteria focused on peer-reviewed studies in English, detailing outcomes relevant to ocular recovery such as tear film stability, ocular surface integrity, patient-reported discomfort, or visual acuity (VA). The quality of the included studies was assessed using the Cochrane Risk of Bias Tool and synthesized the data qualitatively.</p><p><strong>Results: </strong>Four qualitative investigations met the inclusion criteria. The studies collectively assessed the efficacy of a 3% trehalose and 0.15% hyaluronic acid eye drop solution in reducing postoperative eye symptoms compared to various control solutions. Parameters measured included tear break-up time (TBUT), Fluorescein staining, tear production (Schirmer test), and Ocular Surface Disease Index (OSDI) scores. The results indicated significant improvements in tear film stability and ocular surface health for the treatment groups compared to controls, with a notable decrease in patient-reported discomfort. The study showed an improvement of - 18 (± 14.6) in the treatment group compared to - 7 (± 8.0) in the control group for OSDI. For TBUT, the treatment group improved by 3 (± 1.2) s, whereas the control group improved by 0.3 (± 0.71) s. VA, measured on a scale of 0-100, increased to 17 (± 0.7) in the treatment group compared to 15 (± 1.1) in the control group.</p><p><strong>Conclusions: </strong>Trehalose and hyaluronic acid may be beneficial in the postoperative period by enhancing tear film stability and ocular surface health. While the results are promising, further research is needed to confirm these findings, understand the mechanisms of action, and explore broader applications.</p>","PeriodicalId":14473,"journal":{"name":"International Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10792-024-03308-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This Systematic review aims to assess the efficacy of trehalose and hyaluronic acid in enhancing ocular recovery post-cataract surgery, focusing on their impact on tear film stability, ocular surface integrity, and patient-reported outcomes.

Methods: A comprehensive search was conducted across MEDLINE, PubMed, and Cochrane Library databases to identify randomized controlled trials investigating the efficacy of trehalose, hyaluronic acid, or their combination in post-cataract surgery care. The inclusion criteria focused on peer-reviewed studies in English, detailing outcomes relevant to ocular recovery such as tear film stability, ocular surface integrity, patient-reported discomfort, or visual acuity (VA). The quality of the included studies was assessed using the Cochrane Risk of Bias Tool and synthesized the data qualitatively.

Results: Four qualitative investigations met the inclusion criteria. The studies collectively assessed the efficacy of a 3% trehalose and 0.15% hyaluronic acid eye drop solution in reducing postoperative eye symptoms compared to various control solutions. Parameters measured included tear break-up time (TBUT), Fluorescein staining, tear production (Schirmer test), and Ocular Surface Disease Index (OSDI) scores. The results indicated significant improvements in tear film stability and ocular surface health for the treatment groups compared to controls, with a notable decrease in patient-reported discomfort. The study showed an improvement of - 18 (± 14.6) in the treatment group compared to - 7 (± 8.0) in the control group for OSDI. For TBUT, the treatment group improved by 3 (± 1.2) s, whereas the control group improved by 0.3 (± 0.71) s. VA, measured on a scale of 0-100, increased to 17 (± 0.7) in the treatment group compared to 15 (± 1.1) in the control group.

Conclusions: Trehalose and hyaluronic acid may be beneficial in the postoperative period by enhancing tear film stability and ocular surface health. While the results are promising, further research is needed to confirm these findings, understand the mechanisms of action, and explore broader applications.

评估树胶糖和透明质酸的治疗作用:对患者护理的影响。
目的:本系统综述旨在评估曲哈洛糖和透明质酸在促进白内障术后眼部恢复方面的疗效,重点关注它们对泪膜稳定性、眼表完整性和患者报告结果的影响:方法:在 MEDLINE、PubMed 和 Cochrane Library 数据库中进行了全面搜索,以确定研究曲阿糖、透明质酸或它们在白内障术后护理中的组合功效的随机对照试验。纳入标准侧重于同行评议的英文研究,详细说明与眼部恢复相关的结果,如泪膜稳定性、眼表完整性、患者报告的不适感或视力(VA)。我们使用 Cochrane 偏倚风险工具对纳入研究的质量进行了评估,并对数据进行了定性综合:结果:四项定性调查符合纳入标准。这些研究共同评估了 3% 曲哈洛糖和 0.15% 透明质酸滴眼液与各种对照溶液相比在减轻术后眼部症状方面的疗效。测量的参数包括泪液破裂时间(TBUT)、荧光素染色、泪液分泌量(Schirmer 试验)和眼表疾病指数(OSDI)评分。结果表明,与对照组相比,治疗组的泪膜稳定性和眼表健康状况明显改善,患者报告的不适感明显减少。研究显示,治疗组的 OSDI 改善了-18(± 14.6)分,而对照组则为-7(± 8.0)分。在TBUT方面,治疗组改善了3(± 1.2)秒,而对照组改善了0.3(± 0.71)秒。以0-100分衡量,治疗组的VA增加到17(± 0.7)分,而对照组为15(± 1.1)分:结论:曲哈洛糖和透明质酸可增强泪膜稳定性和眼表健康,对术后有益。虽然这些结果很有希望,但还需要进一步的研究来证实这些发现,了解其作用机制,并探索更广泛的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.20
自引率
0.00%
发文量
451
期刊介绍: International Ophthalmology provides the clinician with articles on all the relevant subspecialties of ophthalmology, with a broad international scope. The emphasis is on presentation of the latest clinical research in the field. In addition, the journal includes regular sections devoted to new developments in technologies, products, and techniques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信